Phase III trial of LX 4211 in patients with type 2 diabetes mellitus.
Phase of Trial: Phase III
Latest Information Update: 09 Sep 2016
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi
- 09 Sep 2016 According to a Lexicon media release, Sanofi is expected to commence this study by the end of the 2016.
- 02 Mar 2016 Planned initiation date changed from 1 Jan 2016 to 1 Nov 2016, as reported by Lexicon media release.
- 09 Feb 2016 Planned initiation date changed to 1 Jan 2016, according to a Sanofi media release.